NJ State Employees Deferred Compensation Plan - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 220 filers reported holding FIBROGEN INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$12,081
-68.0%
14,0000.0%0.00%
-60.0%
Q2 2023$37,800
-86.5%
14,000
-6.7%
0.01%
-88.4%
Q1 2023$279,900
+16.5%
15,0000.0%0.04%
+10.3%
Q4 2022$240,300
+23.2%
15,0000.0%0.04%
+18.2%
Q3 2022$195,000
+22.6%
15,0000.0%0.03%
+26.9%
Q2 2022$159,000
-11.7%
15,0000.0%0.03%
+8.3%
Q1 2022$180,000
-14.7%
15,0000.0%0.02%
-11.1%
Q4 2021$211,000
+37.9%
15,0000.0%0.03%
+28.6%
Q3 2021$153,000
-61.8%
15,0000.0%0.02%
-60.4%
Q2 2021$400,000
-23.2%
15,0000.0%0.05%
-28.4%
Q1 2021$521,000
+56.0%
15,000
+66.7%
0.07%
+42.3%
Q4 2020$334,000
-9.7%
9,0000.0%0.05%
-21.2%
Q3 2020$370,000
+1.4%
9,0000.0%0.07%
-4.3%
Q2 2020$365,000
+16.6%
9,0000.0%0.07%
-4.2%
Q1 2020$313,000
-18.9%
9,0000.0%0.07%
+9.1%
Q4 2019$386,000
+15.9%
9,0000.0%0.07%
+8.2%
Q3 2019$333,000
+22.9%
9,000
+50.0%
0.06%
+24.5%
Q2 2019$271,000
-16.9%
6,0000.0%0.05%
-16.9%
Q1 2019$326,000
+41.1%
6,000
+20.0%
0.06%
+22.9%
Q4 2018$231,000
+7.4%
5,000
+25.0%
0.05%
+23.1%
Q3 2017$215,000
-53.7%
4,000
-72.1%
0.04%
-55.7%
Q2 2017$464,000
+31.1%
14,3520.0%0.09%
+31.3%
Q1 2017$354,000
+15.3%
14,3520.0%0.07%
+9.8%
Q4 2016$307,000
+3.4%
14,3520.0%0.06%0.0%
Q3 2016$297,000
+25.8%
14,3520.0%0.06%
+22.0%
Q2 2016$236,000
-25.8%
14,3520.0%0.05%
-26.5%
Q1 2016$318,000
-27.2%
14,3520.0%0.07%
-24.4%
Q4 2015$437,000
+38.7%
14,3520.0%0.09%
+32.4%
Q3 2015$315,00014,3520.07%
Other shareholders
FIBROGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders